Literature DB >> 19141440

Adeno-associated virus type 5 exploits two different entry pathways in human embryo fibroblasts.

Ursula Bantel-Schaal1, Ilona Braspenning-Wesch1, Juergen Kartenbeck2.   

Abstract

The helper-dependent adeno-associated viruses (AAVs) have attracted great interest as vectors for gene therapy. Uptake and intracellular trafficking pathways of AAV are of importance, since they are often rate-limiting steps in infection. Here, we have investigated the entry of AAV type 5 (AAV5) in primary human embryo fibroblasts. At low binding temperatures, numerous virions are concentrated between cells, at contact points between cells and cellular protrusions, and at filopodia. When the temperature is raised to 37 degrees C, uptake of AAV5 takes place but up to 80 % of the bound virions dissociate from the cells. Uptake is achieved by cellular structures that are part of at least two different entry pathways. In addition to the common clathrin-dependent route, caveolar endocytosis and caveosome-like organelles are involved in a second pathway not yet described for parvoviruses. Both pathways can be used in parallel to enter an individual cell.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19141440     DOI: 10.1099/vir.0.005595-0

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  17 in total

Review 1.  Adeno-associated Virus as a Mammalian DNA Vector.

Authors:  Max Salganik; Matthew L Hirsch; Richard Jude Samulski
Journal:  Microbiol Spectr       Date:  2015-08

2.  Unique characteristics of AAV1, 2, and 5 viral entry, intracellular trafficking, and nuclear import define transduction efficiency in HeLa cells.

Authors:  Nicholas W Keiser; Ziying Yan; Yulong Zhang; Diana C M Lei-Butters; John F Engelhardt
Journal:  Hum Gene Ther       Date:  2011-06-28       Impact factor: 5.695

3.  Polymeric nucleic acid vehicles exploit active interorganelle trafficking mechanisms.

Authors:  Katye M Fichter; Nilesh P Ingle; Patrick M McLendon; Theresa M Reineke
Journal:  ACS Nano       Date:  2012-12-31       Impact factor: 15.881

Review 4.  Gene therapy for heart failure.

Authors:  Lisa Tilemann; Kiyotake Ishikawa; Thomas Weber; Roger J Hajjar
Journal:  Circ Res       Date:  2012-03-02       Impact factor: 17.367

5.  Multiple pathways involved in porcine parvovirus cellular entry and trafficking toward the nucleus.

Authors:  Maude Boisvert; Sandra Fernandes; Peter Tijssen
Journal:  J Virol       Date:  2010-05-19       Impact factor: 5.103

6.  Recombinant adeno-associated virus utilizes cell-specific infectious entry mechanisms.

Authors:  Marc S Weinberg; Sarah Nicolson; Aadra P Bhatt; Michael McLendon; Chengwen Li; R Jude Samulski
Journal:  J Virol       Date:  2014-08-20       Impact factor: 5.103

7.  Characterization of the early steps of human parvovirus B19 infection.

Authors:  Silva Quattrocchi; Nico Ruprecht; Claudia Bönsch; Sven Bieli; Christoph Zürcher; Klaus Boller; Christoph Kempf; Carlos Ros
Journal:  J Virol       Date:  2012-06-20       Impact factor: 5.103

Review 8.  Intracellular transport of recombinant adeno-associated virus vectors.

Authors:  M Nonnenmacher; T Weber
Journal:  Gene Ther       Date:  2012-02-23       Impact factor: 5.250

9.  Early steps in cell infection by parvoviruses: host-specific differences in cell receptor binding but similar endosomal trafficking.

Authors:  Carole E Harbison; Sangbom Michael Lyi; Wendy S Weichert; Colin R Parrish
Journal:  J Virol       Date:  2009-08-05       Impact factor: 5.103

10.  Parvovirus particles and movement in the cellular cytoplasm and effects of the cytoskeleton.

Authors:  Sangbom Michael Lyi; Min Jie Alvin Tan; Colin R Parrish
Journal:  Virology       Date:  2014-04-25       Impact factor: 3.616

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.